IGM Biosciences Inc
NASDAQ:IGMS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
IGM Biosciences Inc
NASDAQ:IGMS
|
US |
|
Pros Holdings Inc
NYSE:PRO
|
US |
|
SAP SE
OTC:SAPGF
|
DE |
|
AppYea Inc
OTC:APYP
|
IL |
|
F
|
Fluor Corp
DUS:FLU
|
US |
|
C
|
Cascades Inc
OTC:CADNF
|
CA |
|
M
|
Myriad Genetics Inc
DUS:MYD
|
US |
|
Maple Leaf Foods Inc
TSX:MFI
|
CA |
|
QinetiQ Group PLC
LSE:QQ
|
UK |
|
Bigtincan Holdings Ltd
ASX:BTH
|
AU |
|
Coty Inc
PAR:COTY
|
US |
|
C
|
ConvaTec Group PLC
OTC:CNVVY
|
UK |
|
Organizacion Soriana SAB de CV
F:OSOB
|
MX |
|
Pacific Ridge Exploration Ltd
XTSX:PEX
|
CA |
|
B
|
Bridgestone Corp
OTC:BRDCF
|
JP |
|
G
|
Golfzon Co Ltd
KOSDAQ:215000
|
KR |
|
Cincinnati Financial Corp
NASDAQ:CINF
|
US |
|
JFE Holdings Inc
F:JFR
|
JP |
|
Harley-Davidson Inc
NYSE:HOG
|
US |
|
HeidelbergCement AG
XETRA:HEI
|
DE |
|
Vidrala SA
OTC:VDRFF
|
ES |
|
Chocoladefabriken Lindt & Spruengli AG
SIX:LISN
|
CH |
|
L
|
Loblaw Companies Ltd
F:L8G
|
CA |
|
Medical Properties Trust Inc
NYSE:MPW
|
US |
Bankruptcy Probability
IGM Biosciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
IGM Biosciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
IGM Biosciences Inc
NASDAQ:IGMS
|
76.2m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
386.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
65.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
44.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
IGM Biosciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, IGM Biosciences Inc has no debt.
You can find a full breakdown on its Balance Sheet.
